Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
The prognostic value of microvessel density (MVD) in head and neck squamous cell carcinoma (HNSCC) remains disputable. The purpose of this study was to comprehensively determine the prognostic value of MVD in HNSCC. Relevant literatures were identified using PubMed, Embase, and Cochrane Library. A m...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2020/8842795 |
id |
doaj-761a30b5067a48259b6c99693306c86f |
---|---|
record_format |
Article |
spelling |
doaj-761a30b5067a48259b6c99693306c86f2020-11-25T02:41:58ZengHindawi LimitedDisease Markers0278-02401875-86302020-01-01202010.1155/2020/88427958842795Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-AnalysisYanbo Dong0Guangzhi Ma1Yukun Liu2Siyu Lu3Liangfa Liu4Department of Otolaryngology Head and Neck Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, ChinaDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, ChinaDepartment of Emergency, Aviation General Hospital, Beijing 100012, ChinaDepartment of Otolaryngology Head and Neck Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaThe prognostic value of microvessel density (MVD) in head and neck squamous cell carcinoma (HNSCC) remains disputable. The purpose of this study was to comprehensively determine the prognostic value of MVD in HNSCC. Relevant literatures were identified using PubMed, Embase, and Cochrane Library. A meta-analysis was performed to clarify the prognostic role of MVD in HNSCC patients and different subgroups. A total of 14 eligible articles were included in this meta-analysis. The combined hazard ratio (HR) and 95% confidence interval (95% CI) for overall survival (OS) of 11 studies was 1.663 (1.236-2.237, P=0.001), and the pooled HR and 95% CI for progression-free survival (PFS) of 7 studies was 2.069 (1.281-3.343, P=0.003). Subgroup analyses were also performed on different issues, such as regional distribution of patients, age, tumor location, antibody, and treatment strategy. To conclude, high MVD is associated with worse OS and PFS in patients with HNSCC.http://dx.doi.org/10.1155/2020/8842795 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yanbo Dong Guangzhi Ma Yukun Liu Siyu Lu Liangfa Liu |
spellingShingle |
Yanbo Dong Guangzhi Ma Yukun Liu Siyu Lu Liangfa Liu Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis Disease Markers |
author_facet |
Yanbo Dong Guangzhi Ma Yukun Liu Siyu Lu Liangfa Liu |
author_sort |
Yanbo Dong |
title |
Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis |
title_short |
Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis |
title_full |
Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis |
title_fullStr |
Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis |
title_full_unstemmed |
Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis |
title_sort |
prognostic value of microvessel density in head and neck squamous cell carcinoma: a meta-analysis |
publisher |
Hindawi Limited |
series |
Disease Markers |
issn |
0278-0240 1875-8630 |
publishDate |
2020-01-01 |
description |
The prognostic value of microvessel density (MVD) in head and neck squamous cell carcinoma (HNSCC) remains disputable. The purpose of this study was to comprehensively determine the prognostic value of MVD in HNSCC. Relevant literatures were identified using PubMed, Embase, and Cochrane Library. A meta-analysis was performed to clarify the prognostic role of MVD in HNSCC patients and different subgroups. A total of 14 eligible articles were included in this meta-analysis. The combined hazard ratio (HR) and 95% confidence interval (95% CI) for overall survival (OS) of 11 studies was 1.663 (1.236-2.237, P=0.001), and the pooled HR and 95% CI for progression-free survival (PFS) of 7 studies was 2.069 (1.281-3.343, P=0.003). Subgroup analyses were also performed on different issues, such as regional distribution of patients, age, tumor location, antibody, and treatment strategy. To conclude, high MVD is associated with worse OS and PFS in patients with HNSCC. |
url |
http://dx.doi.org/10.1155/2020/8842795 |
work_keys_str_mv |
AT yanbodong prognosticvalueofmicrovesseldensityinheadandnecksquamouscellcarcinomaametaanalysis AT guangzhima prognosticvalueofmicrovesseldensityinheadandnecksquamouscellcarcinomaametaanalysis AT yukunliu prognosticvalueofmicrovesseldensityinheadandnecksquamouscellcarcinomaametaanalysis AT siyulu prognosticvalueofmicrovesseldensityinheadandnecksquamouscellcarcinomaametaanalysis AT liangfaliu prognosticvalueofmicrovesseldensityinheadandnecksquamouscellcarcinomaametaanalysis |
_version_ |
1715412344547311616 |